PXD033145 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Mass spectroscopy-based proteomics and metabolomics analysis of BT- 474 breast cancer cells treated with Tamoxifen and/or Trastuzumab |
Description | `Triple positive` BT-474 breast cancer cells were treated with anti-cancer compounds, Tamoxifen and Trastuzumab, and the metabolome and proteome analysed by LC-MS/MS using a timsTOF. |
HostingRepository | PRIDE |
AnnounceDate | 2023-11-14 |
AnnouncementXML | Submission_2023-11-14_08:56:08.813.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Alexander Giddey |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | No PTMs are included in the dataset |
Instrument | timsTOF |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2022-04-11 02:46:59 | ID requested | |
1 | 2023-01-17 00:17:50 | announced | |
⏵ 2 | 2023-11-14 08:56:09 | announced | 2023-11-14: Updated project metadata. |
Publication List
Dataset with its publication pending |
Keyword List
submitter keyword: anti-cancer, LC-MSMS,timsTOF, human, cells |
Contact List
Mohammad Semreen |
contact affiliation | University of Sharjah |
contact email | msemreen@sharjah.ac.ae |
lab head | |
Alexander Giddey |
contact affiliation | University of Cape Town |
contact email | gddale001@myuct.ac.za |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2023/01/PXD033145 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD033145
- Label: PRIDE project
- Name: Mass spectroscopy-based proteomics and metabolomics analysis of BT- 474 breast cancer cells treated with Tamoxifen and/or Trastuzumab